Patient Dies After Experimental Cell Therapy in Bristol Myers Squibb Study
Bristol Myers Squibb said a patient in its multiple sclerosis study died after receiving the experimental cell therapy. The patient developed movement-related problems after the infusion and died 44 days later. BMY shares fell 2.4%.
Bristol Myers Squibb said Friday that a patient in its multiple sclerosis study died after receiving the experimental cell therapy. The stock fell 2.4%. The patient developed movement-related problems after the infusion and died 44 days after receiving the drug.